JSC "Gryndeks" (manufacturer responsible for batch release, including batch control/testing)

The drug is used to treat diseases of the peripheral nervous system (e.g., myasthenia, neuropathies) and diseases of the central nervous system (bulbar paralysis, recovery after CNS damage). It also helps to improve memory and slow the progression of dementia.

Dosage form: solution for injection

ATC: N07AA

The drug is used for the short-term relief of moderate to severe pain following surgical operations. Treatment must be conducted only in an inpatient setting.

Dosage form: solution for injection

ATC: M01AB15